share_log

Morgan Stanley Maintains Underweight on PetMed Express, Lowers Price Target to $18

Morgan Stanley Maintains Underweight on PetMed Express, Lowers Price Target to $18

摩根士丹利维持对PetMed Express的减持,将目标股价下调至18美元
Benzinga Real-time News ·  2022/11/08 09:22

Morgan Stanley analyst Erin Wright maintains PetMed Express (NASDAQ:PETS) with a Underweight and lowers the price target from $19 to $18.

摩根士丹利分析师艾琳·赖特维持PetMed Express(纳斯达克股票代码:PETS)持有减持,并将目标股价从19美元下调至18美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发